| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS30011012 | HIV | ENSG00000005249.14 | protein_coding | PRKAR2B | No | No | 5577 | P31323 |
| TVIS30078023 | HIV | ENSG00000005249.14 | protein_coding | PRKAR2B | No | No | 5577 | P31323 |
| TVIS20061591 | HPV | ENSG00000005249.14 | protein_coding | PRKAR2B | No | No | 5577 | P31323 |
| TVIS44033790 | HTLV-1 | ENSG00000005249.14 | protein_coding | PRKAR2B | No | No | 5577 | P31323 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | PRKAR2B |
|---|---|
| DrugBank ID | DB02527 |
| Drug Name | Cyclic adenosine monophosphate |
| Target ID | BE0004497 |
| UniProt ID | P31323 |
| Regulation Type | |
| PubMed IDs | 17139284; 17016423; 10592235 |
| Citations | Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.@@Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.@@Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. |
| Groups | Experimental |
| Direct Classification | 3',5'-cyclic purine nucleotides |
| SMILES | NC1=C2N=CN([C@@H]3O[C@@H]4COP(O)(=O)O[C@H]4[C@H]3O)C2=NC=N1 |
| Pathways | Molybdenum Cofactor Deficiency; Excitatory Neural Signalling Through 5-HTR 6 and Serotonin; Intracellular Signalling Through FSH Receptor and Follicle Stimulating Hormone; Xanthinuria Type I; Azathioprine Action Pathway; AICA-Ribosiduria; Lysophosphatidic Acid LPA5 Signalling; Excitatory Neural Signalling Through 5-HTR 7 and Serotonin; Purine Nucleoside Phosphorylase Deficiency; Lysophosphatidic Acid LPA6 Signalling; Excitatory Neural Signalling Through 5-HTR 4 and Serotonin; Vasopressin Regulation of Water Homeostasis; Corticotropin Activation of Cortisol Production; Thioguanine Action Pathway; Intracellular Signalling Through Histamine H2 Receptor and Histamine; Xanthine Dehydrogenase Deficiency (Xanthinuria); Intracellular Signalling Through PGD2 receptor and Prostaglandin D2; Intracellular Signalling Through Adenosine Receptor A2b and Adenosine; Purine Metabolism; Intracellular Signalling Through Adenosine Receptor A2a and Adenosine; Lysophosphatidic Acid LPA1 Signalling; Mitochondrial DNA Depletion Syndrome; Adenosine Deaminase Deficiency; Lysophosphatidic Acid LPA4 Signalling; Xanthinuria Type II; Myoadenylate Deaminase Deficiency; Lysophosphatidic Acid LPA2 Signalling; Intracellular Signalling Through Prostacyclin Receptor and Prostacyclin; Dopamine Activation of Neurological Reward System; Adenylosuccinate Lyase Deficiency |
| PharmGKB | |
| ChEMBL | CHEMBL316966 |
